TGF-β inhibitors for the treatment of cancer

被引：65
|
作者：
Lahn, M [1 ]
Kloeker, S [1 ]
Berry, BS [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Therapeut Area Oncol, Indianapolis, IN 46285 USA
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2005年 / 14卷 / 06期
关键词：
antisense oligonucleotide; cancer; clinical Studies; knockout mice; monoclonal antibodies; TGF-beta; TGF-beta RI kinase inhibitors;
D O I：
10.1517/13543784.14.6.629
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Advances in understanding the role of transforming growth factor (TGF)-beta in tumorigenesis have led to the development of TGF-beta inhibitors for cancer treatment. Three platforms of TGF-beta inhibitors have evolved: antisense oligonucleotides, monoclonal antibodies and small molecules. in this review, the current stage of development of each known TGF-beta inhibitor will be discussed. As part of the risk/benefit assessment of TGF-beta inhibitors, the known effects of TGF-beta deficiency in mice, non-clinical toxicology studies with TGF-beta inhibitors in rats, and the clinical studies with monoclonal antibodies against TGF-beta will be summarised.
引用
收藏
页码：629 / 641
页数：13
相关论文
共 50 条
  • [41] TGF-β Signaling and Resistance to Cancer Therapy
    Zhang, Maoduo
    Zhang, Ying Yi
    Chen, Yongze
    Wang, Jia
    Wang, Qiang
    Lu, Hezhe
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] The TGF-β paradox in human cancer: an update
    Tian, Maozhen
    Schiemann, William P.
    FUTURE ONCOLOGY, 2009, 5 (02) : 259 - 271
  • [43] Antibody Targeting of TGF-β in Cancer Patients
    Lonning, Scott
    Mannick, Joan
    McPherson, John M.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2176 - 2189
  • [44] Chronic liver injury, TGF-β, and cancer
    Bissell, DM
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) : 179 - 190
  • [45] TGF-β/Smad signaling in prostate cancer
    Bello-DeOcampo, D
    Tindall, DJ
    CURRENT DRUG TARGETS, 2003, 4 (03) : 197 - 207
  • [46] TrkC binds to the type II TGF-β receptor to suppress TGF-β signaling
    Jin, W.
    Yun, C.
    Kwak, M-K
    Kim, T-A
    Kim, S-J
    ONCOGENE, 2007, 26 (55) : 7684 - 7691
  • [47] Defective TGF-β signaling sensitizes human cancer cells to rapamycin
    Gadir, N.
    Jackson, D. N.
    Lee, E.
    Foster, D. A.
    ONCOGENE, 2008, 27 (08) : 1055 - 1062
  • [48] The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
    Mishra, L
    Shetty, K
    Tang, Y
    Stuart, A
    Byers, SW
    ONCOGENE, 2005, 24 (37) : 5775 - 5789
  • [49] Angiotensin Inhibition, TGF-β and EMT in Cancer
    Pallasch, Fabian Bernhard
    Schumacher, Udo
    CANCERS, 2020, 12 (10) : 1 - 22
  • [50] TGF-β and cancer:: Is Smad3 a repressor of hTERT gene?
    Li, H
    Xu, DK
    Toh, BH
    Liu, JP
    CELL RESEARCH, 2006, 16 (02) : 169 - 173
12345